Mark C. Schiller - 02 Jul 2025 Form 4 Insider Report for Kezar Life Sciences, Inc. (KZR)

Role: Chief Operating Officer
Signature: /s/ Marc Belsky, Attorney-in-Fact
Issuer symbol: KZR
Transactions as of: 02 Jul 2025
Net transactions value: -$2,401
Form type: 4
Filing time: 03 Jul 2025, 16:15:27 UTC
Previous filing: 01 Apr 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Schiller Mark C.	Chief Operating Officer	C/O KEZAR LIFE SCIENCES, INC., 4000 SHORELINE COURT, SUITE 300, SOUTH SAN FRANCISCO	/s/ Marc Belsky, Attorney-in-Fact	03 Jul 2025	0002007659

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	KZR	Common Stock	Sale	$2,401	-561	-17%	$4.28	2,739	02 Jul 2025	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting of restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of statutory tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary sale by the Reporting Person.

Content

Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting of restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of statutory tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary sale by the Reporting Person.